Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe IPD sharing documentation has been updated to Revision v3.6.3, replacing the prior v3.6.2. This reflects an administrative update to the data-sharing materials for the study.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor version update to the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page now states that the study is no longer enrolling participants, with a minor formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a small version update without visible changes to the page content.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded related topic tags for Rheumatoid arthritis and MedlinePlus Genetics to the page's metadata. Updated the site revision from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check72 days agoChange DetectedThese updates reflect a small normalization of a listed location spelling (Ādaži → Adazi) and a non-clinical update to the ClinicalTrials.gov page software revision (v3.5.2 → v3.5.3).SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.